Alon Ben Noon
CEO, NeuroSense Therapeutics
Alon Ben-Noon is co-founder and CEO of NeuroSense Therapeutics, a drug development company focusing on the treatment of ALS and other neurodegenerative diseases.
Show Notes
01:13 Tell us about your career journey and meeting Shay Rishoni
06:25 Tell us about ALS and why it has become a relatively well-known orphan indication
09:30 Tell us about PrimceC
12:40 Could you talk about your financing journey
16:13 Did the crowdfunding process affect your public offering in some sort of way?
18:54 Is it true that zebrafish have over 70% genetic similarity to humans? How is that even possible?
21:00 Could you expand on the leadership team at NeuroSense?
23:10 How has your personal life changed since the company was floated to NASDAQ?
25:00 You have a very unique organizational culture in NeuroSense Therapeutics and you're growing. How do you intend to keep some of that culture while you grow?
27:30 What’s next forNeuroSense? What are the next milestones and pipeline products?
30:15 How long do you expect you are away from the market with the PrimeC?
31:05 Have you put any thoughts to having a companion diagnostic?
32:25 What are your thoughts about the Israeli ecosystem?
34:25 If you could go back to your 16-year-old self and tell yourself something, what do you think it would be?
35:40 Are there any people in your journey that were meaningful to you personally and to NeuroSense Therapeutics
Interview Transcription (mild edits)
Coming soon
Links
(More) Amazing people to learn from
Daniella Gilboa is the CEO of AIVF, a company is out to transform the fertility and IVF treatment journey.
Lena Levin is the co-founder and Via Surgical, the first and only company to create suture-like fixation solutions to address imminent market needs. Her previous venture PolyTouch Medical was acquired back in 2011.
Michal Geva is Co-founder and Managing Partner of Triventures. She is one of the most prominent investors in Israel's MedTech and digital health scene. Michal resides on the boards of many companies and has accumulated a track record of multiple exits.
Gilad Glick is CEO of Itamar Medical, a company that has change the home testing for sleep.
Cecile Blilious is the Head of Impact and Sustainability at Pitango Venture Capital
Professor Varda Shalev, a physician, medical researcher, and professor of medicine at Tel Aviv University’s School of Public Health, is also the co-founder of Alike Health.